JP2019504832A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504832A5 JP2019504832A5 JP2018535329A JP2018535329A JP2019504832A5 JP 2019504832 A5 JP2019504832 A5 JP 2019504832A5 JP 2018535329 A JP2018535329 A JP 2018535329A JP 2018535329 A JP2018535329 A JP 2018535329A JP 2019504832 A5 JP2019504832 A5 JP 2019504832A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sulfated polysaccharide
- composition according
- polypeptide
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662275827P | 2016-01-07 | 2016-01-07 | |
| US62/275,827 | 2016-01-07 | ||
| PCT/IL2017/050013 WO2017118979A1 (en) | 2016-01-07 | 2017-01-05 | Compositions and methods for generating immunotolerant responses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504832A JP2019504832A (ja) | 2019-02-21 |
| JP2019504832A5 true JP2019504832A5 (enExample) | 2019-12-12 |
| JP7033066B2 JP7033066B2 (ja) | 2022-03-09 |
Family
ID=59273512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018535329A Expired - Fee Related JP7033066B2 (ja) | 2016-01-07 | 2017-01-05 | 免疫寛容応答を生成する組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11123404B2 (enExample) |
| EP (1) | EP3400074B1 (enExample) |
| JP (1) | JP7033066B2 (enExample) |
| KR (1) | KR20180104646A (enExample) |
| CN (1) | CN109069875B (enExample) |
| IL (1) | IL260436B2 (enExample) |
| WO (1) | WO2017118979A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA035413B1 (ru) | 2013-06-13 | 2020-06-10 | Ордженисис Лтд. | Популяции клеток, способы трансдифференцировки и способы их применения |
| MA41296A (fr) | 2014-12-30 | 2017-11-07 | Orgenesis Ltd | Procédés de transdifférenciation et procédés d'utilisation de ceux-ci |
| SG11201911256UA (en) | 2017-05-08 | 2020-01-30 | Orgenesis Ltd | Transdifferentiated cell populations and methods of use thereof |
| WO2019171377A1 (en) * | 2018-03-06 | 2019-09-12 | Orgenesis Inc | Three dimensional clusters of transdifferentiated cells, compositions and methods thereof |
| JP2022506154A (ja) * | 2018-11-01 | 2022-01-17 | バークレー ライツ，インコーポレイテッド | マイクロ流体環境において生体細胞をアッセイする方法 |
| CN109771638A (zh) * | 2018-12-28 | 2019-05-21 | 中国人民解放军陆军军医大学第一附属医院 | 一种免疫耐受剂 |
| WO2024080183A1 (ja) * | 2022-10-14 | 2024-04-18 | 国立大学法人東海国立大学機構 | 糖鎖複合体、薬物担体、及びドラッグデリバリーシステム |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4178361A (en) | 1973-09-10 | 1979-12-11 | Union Corporation | Sustained release pharmaceutical composition |
| US5100668A (en) | 1988-06-14 | 1992-03-31 | Massachusetts Institute Of Technology | Controlled release systems containing heparin and growth factors |
| IL118376A0 (en) | 1996-05-22 | 1996-09-12 | Univ Ben Gurion | Polysaccharide sponges for cell culture and transplantation |
| GB9722604D0 (en) | 1997-10-28 | 1997-12-24 | Cancer Res Campaign Tech | Heparin-binding growth factor derivatives |
| US6388060B1 (en) | 1998-11-06 | 2002-05-14 | Vascular Therapeutics Inc. | Process for the sulfation of uronic acid-containing polysaccharides |
| JP2002542301A (ja) | 1999-04-22 | 2002-12-10 | アイトゲネシッシェ、テヒニッシェ、ホッホシューレ（エーテーハー） | ヘパリン含有マトリックスからの増殖因子の制御放出 |
| WO2001066164A1 (en) | 1999-04-22 | 2001-09-13 | Eidgenossisch Technische Hochschule Zurich | Modified protein matrices |
| US6479064B1 (en) | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
| US6773723B1 (en) | 2000-08-30 | 2004-08-10 | Depuy Acromed, Inc. | Collagen/polysaccharide bilayer matrix |
| GB0029847D0 (en) | 2000-12-07 | 2001-01-24 | Univ Bristol | Preparation of spheroids |
| DE60236974D1 (de) | 2001-07-26 | 2010-08-19 | Transparent Inc | Kultiviertes Zellkonstrukt mit Sphäroiden kultivierter Tierzellen und seine Verwendung |
| AU2003217700A1 (en) | 2002-02-26 | 2003-09-09 | Stelsys Llc | Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids |
| US20050069572A1 (en) | 2002-10-09 | 2005-03-31 | Jennifer Elisseeff | Multi-layered polymerizing hydrogels for tissue regeneration |
| CA2556169C (en) | 2004-01-29 | 2011-11-22 | Andrew Lees | Use of amino-oxy functional groups in the preparation of vaccines |
| FR2871379B1 (fr) * | 2004-06-14 | 2006-09-29 | Ifremer | Utilisation de derives polysaccharidiques hautement sulfates et de faible masse molaire pour moduler l'angiogenese |
| CN101068574B (zh) | 2004-07-20 | 2012-07-18 | 伊索格尼斯股份有限公司 | 与自身抗原有关的自身免疫和疾病的特异性抑制 |
| US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
| US7517856B2 (en) | 2005-10-11 | 2009-04-14 | Ben-Gurion University Of The Negev Research And Development Authority | Bioconjugates comprising sulfated polysaccharides and their uses |
| EP1886696A1 (en) | 2006-08-03 | 2008-02-13 | Endotis Pharma | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
| US8275594B2 (en) | 2006-10-30 | 2012-09-25 | The Regents Of The University Of Michigan | Engineered scaffolds for intervertebral disc repair and regeneration and for articulating joint repair and regeneration |
| ES2322637B1 (es) | 2007-06-26 | 2010-03-05 | Universidad Del Pais Vasco | Microparticulas de alginato modificado con rgd como sistema de liberacion de farmacos. |
| IL187707A0 (en) | 2007-11-27 | 2008-11-03 | Univ Ben Gurion | Alginate scaffold in hepatectomy |
| WO2010030964A2 (en) | 2008-09-12 | 2010-03-18 | The Brigham And Women's Hospital, Inc. | 3-dimensional multi-layered hydrogels and methods of making the same |
| WO2010056378A2 (en) | 2008-11-14 | 2010-05-20 | Histogen, Inc. | Extracellular matrix compositions for the treatment of cancer |
| WO2011078990A1 (en) * | 2009-12-14 | 2011-06-30 | Benaroya Research Institute At Virginia Mason | Hydrogels comprising hyaluronan and at least one t cell induction agent |
| US20120321665A1 (en) * | 2009-12-14 | 2012-12-20 | Benaroya Research Institute At Virginia Mason | Compositions and methods for treating airway inflammatory diseases |
| JP6294666B2 (ja) * | 2010-04-13 | 2018-03-14 | イミュノバティブ セラピーズ，リミテッド | 制御性ｔ細胞の阻害のための方法および組成物 |
| WO2011163568A1 (en) | 2010-06-24 | 2011-12-29 | University Of Kansas | Conjugates comprising an n-oxime bond and associated methods |
| EP2678048B1 (en) | 2011-02-22 | 2018-11-21 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Nano-reservoirs technology for use in bone and/or cartilage regeneration |
| EP2816964B1 (en) | 2012-02-21 | 2023-12-27 | Ben-Gurion University of The Negev Research and Development Authority | Hydrogel system comprising spatially separated bioactive polypeptides |
| MX385999B (es) * | 2013-06-18 | 2025-03-18 | Replicel Life Sciences Inc | Composiciones y métodos para tratamiento de la piel. |
| WO2017175229A1 (en) * | 2016-04-07 | 2017-10-12 | B.G. Negev Technologies And Applications Ltd. | Polysaccharide compositions and uses thereof |
-
2017
- 2017-01-05 KR KR1020187022661A patent/KR20180104646A/ko not_active Ceased
- 2017-01-05 EP EP17735926.2A patent/EP3400074B1/en active Active
- 2017-01-05 WO PCT/IL2017/050013 patent/WO2017118979A1/en not_active Ceased
- 2017-01-05 US US16/068,133 patent/US11123404B2/en active Active
- 2017-01-05 CN CN201780015637.XA patent/CN109069875B/zh not_active Expired - Fee Related
- 2017-01-05 JP JP2018535329A patent/JP7033066B2/ja not_active Expired - Fee Related
-
2018
- 2018-07-05 IL IL260436A patent/IL260436B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504832A5 (enExample) | ||
| Luttikhuizen et al. | Cellular and molecular dynamics in the foreign body reaction | |
| Xie et al. | Osteoimmunomodulatory effects of biomaterial modification strategies on macrophage polarization and bone regeneration | |
| Wang et al. | Silk fibroin enhances peripheral nerve regeneration by improving vascularization within nerve conduits | |
| Tajdaran et al. | Matrices, scaffolds, and carriers for protein and molecule delivery in peripheral nerve regeneration | |
| Sklenářová et al. | Collagen as a biomaterial for skin and corneal wound healing | |
| Doorn et al. | Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements | |
| Chung et al. | Crosstalk between mesenchymal stem cells and macrophages in tissue repair | |
| Baldo | Side effects of cytokines approved for therapy | |
| Li et al. | In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor | |
| Zeng et al. | Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury | |
| Cavaillon | Pro-versus anti-inflammatory cytokines: myth or reality | |
| Khoury et al. | Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. | |
| Spiller et al. | Macrophages modulate engineered human tissues for enhanced vascularization and healing | |
| US20150320833A1 (en) | Ossification-inducing compositions and methods of use thereof | |
| Buckley et al. | Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease | |
| CN109069875B (zh) | 产生免疫耐受反应的组合物和方法 | |
| Liguori et al. | Bioactive decellularized cardiac extracellular matrix-based hydrogel as a sustained-release platform for human adipose tissue-derived stromal cell-secreted factors | |
| JP2013506681A (ja) | 腎損傷の処置における使用のための造血幹細胞 | |
| St Clair | Interleukin 10 treatment for rheumatoid arthritis | |
| Yin et al. | SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats | |
| CA2734189A1 (en) | Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof | |
| Otani et al. | Optimal amount of basic fibroblast growth factor in gelatin sponges incorporating β-tricalcium phosphate with chondrocytes | |
| WO2015041357A1 (ja) | 免疫抑制剤フリーの移植のためのデバイス、方法及び使用 | |
| Pluchino et al. | Remodelling the injured CNS through the establishment of atypical ectopic perivascular neural stem cell niches |